Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335072 · ClinicalTrials.gov registry record · Phase 4
Kebele Elimination of Trachoma for Ocular Health
A Phase 4 study of Trachoma, sponsored by University of California, San Francisco.
- Active
- Registry status
- Phase 4
- Development phase
- 320,000
- Enrollment target
- 2
- Study locations
NCT03335072: Active Phase 4 study of Trachoma, sponsored by University of California, San Francisco.
NCT03335072 is a Phase 4 study of Trachoma that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 320,000 participants, above the 565-participant average among 4 other Trachoma trials with a reported enrollment target (56537% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03335072, a Phase 4 study of Trachoma, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 320,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Primary Outcome
Assessed by PCR
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (2)
California
- UCSF Proctor Foundation - San Francisco
Other
- Eyu-Ethiopia - Bahir Dar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320,000 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 4 |
What the registry record for NCT03335072 still lists
NCT03335072 is an interventional study that assigns participants to a tested intervention. Its 320,000 participants enrollment target places it among the larger protocols in the corpus, above the 565-participant average among 4 other Trachoma trials with a reported enrollment target (56537% higher).
The record links to 1 condition, with Trachoma appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT03335072 reports a single indexed study location in California, Other.
Frequently Asked Questions
What is clinical trial NCT03335072 about?
NCT03335072 is a clinical study titled "Kebele Elimination of Trachoma for Ocular Health". The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution...
What is the current status of trial NCT03335072?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 320,000 participants. The study started on 2022-02-07. Estimated completion is 2028-03-01.
What conditions does trial NCT03335072 study?
This clinical trial studies the following conditions: Trachoma.
What interventions are being tested in trial NCT03335072?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT03335072?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03335072 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trachoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
COMPLETED · Phase 4
-
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
COMPLETED · Phase 4
-
Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger
COMPLETED · Phase 4
-
A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI